Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Board Approval Details
The Board of Directors of Nephrocare Health Services Limited approved the proposed rationalization and consolidation of the Company's step-down subsidiaries in the Philippines at its meeting held on Friday, September 18, 2026. The meeting commenced at 03:20 p.m. IST and concluded at about 03:45 p.m. IST.
The approval is subject to compliance with applicable laws and receipt of statutory, regulatory, corporate and other required approvals.
Rationale and Purpose
The proposed rationalization and consolidation is intended to:
- Simplify the existing structure of the Group's Philippine operations
- Improve operational, administrative and cost efficiencies
- Strengthen management and governance oversight
- Create a more scalable structure better aligned with the Company's international growth strategy
Entity Structure Details
The restructuring involves Nephrocare Health Care Services Philippines, Inc. ("Nephrocare PH"), a step-down subsidiary of the Company held through Nephrocare Health Services International Pte. Ltd., Singapore. Nephrocare PH currently operates the Group's business in the Philippines through multiple wholly-owned subsidiaries.
Implementation Plan
The consolidation will be implemented in a phased manner, subject to applicable laws and receipt of requisite approvals in both India and the Philippines.
Quantitative and Qualitative Impact
- The transaction represents an internal reorganization of the Group's Philippine operations
- No involvement of third-party investors
- No change in the Company's ultimate economic interest or control over the Philippine operations
- The transaction will be accounted for as a common-control transaction in accordance with applicable accounting framework
- Expected to streamline administrative and compliance processes and optimize costs
Promoter and Shareholding Impact
- No specific benefit to the promoter or promoter group of the Company
- No change in the shareholding pattern of the Company
- No change in ultimate ownership and control of the Philippine business
- Nephrocare PH will continue to remain a step-down subsidiary through Nephrocare Health Services International Pte. Ltd., Singapore
- Only internal reorganization of ownership structure among Philippine entities
Additional Information
The Company shall make further disclosures/updates as required under SEBI Listing Regulations. This information is also available on the company website at www.nephroplus.com.